We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Rapid Detection of Legionella Offered for Commercial Water Systems

By LabMedica International staff writers
Posted on 02 Apr 2018
Print article
Image: In an outbreak of Legionnaires\' disease, finding the exact source as quickly as possible is essential to preventing further infections. Investigators have now developed a rapid test that identifies Legionella pneumophila in less than one hour. The photograph shows the use of the LegioTyper-chip with the MCR microarray analysis platform (Photo courtesy of Jonas Bemetz, Technical University of Munich).
Image: In an outbreak of Legionnaires\' disease, finding the exact source as quickly as possible is essential to preventing further infections. Investigators have now developed a rapid test that identifies Legionella pneumophila in less than one hour. The photograph shows the use of the LegioTyper-chip with the MCR microarray analysis platform (Photo courtesy of Jonas Bemetz, Technical University of Munich).
A rapid (approximately one hour) DNA microarray-based assay is set to replace classical culture methods for identification of Legionella bacteria in commercial water systems.

The genus Legionella is a pathogenic group of Gram-negative bacteria that includes the species L. pneumophila, the causative agent of legionellosis (all illnesses caused by Legionella) including a pneumonia-type illness called Legionnaires' disease.

Molecular biological detection methods capable of rapidly identifying viable Legionella are important for the control of engineered water systems. The current gold standard based on culture methods takes up to 10 days to show positive results. For this reason, investigators at the Technical University of Munich (Germany) developed a flow-based chemiluminescence (CL) DNA microarray that was able to quantify viable and non-viable Legionella spp. as well as L. pneumophila.

The assay method depends on a measuring chip that was developed in the context of the "LegioTyper" project funded by the German Federal Ministry of Education and Research. This chip not only detected the dangerous pathogen L. pneumophila but also identified which of the approximately 20 subtypes was present.

The foil-based measuring chip used the microarray analysis platform MCR marketed by the biotech company GWK GmbH (Munich, Germany). Using 20 different antibodies, this system provided a complete analysis in less than one hour.

"Compared to previous measurements, the new method not only provides a huge speed advantage," said senior author Dr. Michael Seidel, lecturer in analytical chemistry at the Technical University of Munich, "but is also so cheap that we can use the chip in one-time applications."

Related Links:
Technical University of Munich
GWK

Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
New
Urine Analyzer
URIT-180
New
Automated Immunoassay Analyzer
Phadia 1000

Print article

Channels

Immunology

view channel
Image: New insights into preterm infant immunity could inform care (Photo courtesy of 123RF)

New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood

Preterm infants are particularly vulnerable due to their organs still undergoing development, which can lead to difficulties in breathing, eating, and regulating body temperature. This is especially true... Read more

Pathology

view channel
Image: The Results Manager System (Photo courtesy of QuidelOrtho)

Informatics Solution Elevates Laboratory Efficiency and Patient Care

QuidelOrtho Corporation (San Diego, CA, USA) has introduced the QuidelOrtho Results Manager System, a cutting-edge informatics solution designed to meet the increasing demands of modern laboratories.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.